Table 2. Correlation between TSPAN1 expression and multiple clinicopathological characteristics.
| Variables | TSPAN1 expression | P value | ||
|---|---|---|---|---|
| Low | Mid | High | ||
| Age at diagnosis, yr | 0.124 | |||
| < 66 | 10 (18.2%) | 10 (18.2%) | 35 (63.6%) | |
| ≥ 66 | 16 (30.8%) | 13 (25.0%) | 23 (44.2%) | |
| Preoperative PSA, ng/mL | 0.279 | |||
| < 16.0 | 9 (18.8%) | 13 (27.1%) | 26 (54.2%) | |
| ≥ 16.0 | 16 (28.1%) | 9 (15.8%) | 32 (56.1%) | |
| Adverse pathologic events | 0.468 | |||
| Without APE | 18 (21.7%) | 18 (21.7%) | 47 (56.6%) | |
| With APE | 8 (32.0%) | 6 (24.0%) | 11 (44.0%) | |
| Pathologic Gleason score | 0.818 | |||
| ≤ 6 | 5 (22.7%) | 4 (18.2%) | 13 (59.1%) | |
| 7 | 11 (21.6%) | 13 (25.5%) | 27 (52.9%) | |
| ≥ 8 | 10 (31.3%) | 7 (21.9%) | 15 (46.9%) | |